Mario Bezzi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Purpose To evaluate the feasibility of MRgFUS ablation in selected pancreatic and hepatic primary tumors. After giving their informed consent 5 patients with his-tologically proven unresectable pancreatic adenocarci-noma and 1 patient with unresectable right lobe HCC (4 males, 2 females; age range 58-72) underwent MRgFUS treatment on a dedicated 3T unit(More)
  • 1